JP2025515926A5 - - Google Patents

Info

Publication number
JP2025515926A5
JP2025515926A5 JP2024568339A JP2024568339A JP2025515926A5 JP 2025515926 A5 JP2025515926 A5 JP 2025515926A5 JP 2024568339 A JP2024568339 A JP 2024568339A JP 2024568339 A JP2024568339 A JP 2024568339A JP 2025515926 A5 JP2025515926 A5 JP 2025515926A5
Authority
JP
Japan
Prior art keywords
group
hydrogen
pyridine
formula
membered ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024568339A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515926A (ja
Filing date
Publication date
Priority claimed from CN202211018173.7A external-priority patent/CN115353508B/zh
Application filed filed Critical
Publication of JP2025515926A publication Critical patent/JP2025515926A/ja
Publication of JP2025515926A5 publication Critical patent/JP2025515926A5/ja
Pending legal-status Critical Current

Links

JP2024568339A 2022-08-24 2022-11-22 5-ピリジン-1h-インダゾール系化合物、医薬組成物及び使用 Pending JP2025515926A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202211018173.7A CN115353508B (zh) 2022-08-24 2022-08-24 5-吡啶-1h-吲唑类化合物、药物组合物和应用
CN202211018173.7 2022-08-24
PCT/CN2022/133423 WO2024040768A1 (zh) 2022-08-24 2022-11-22 5-吡啶-1h-吲唑类化合物、药物组合物和应用

Publications (2)

Publication Number Publication Date
JP2025515926A JP2025515926A (ja) 2025-05-20
JP2025515926A5 true JP2025515926A5 (https=) 2025-09-25

Family

ID=84003747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024568339A Pending JP2025515926A (ja) 2022-08-24 2022-11-22 5-ピリジン-1h-インダゾール系化合物、医薬組成物及び使用

Country Status (8)

Country Link
US (1) US20260070889A1 (https=)
JP (1) JP2025515926A (https=)
KR (1) KR20250007528A (https=)
CN (1) CN115353508B (https=)
AU (1) AU2022475622A1 (https=)
CA (1) CA3255205A1 (https=)
GB (1) GB2632571A (https=)
WO (1) WO2024040768A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115353508B (zh) * 2022-08-24 2023-07-21 中国药科大学 5-吡啶-1h-吲唑类化合物、药物组合物和应用
CN115785071B (zh) * 2023-01-09 2024-01-26 中国药科大学 3-乙炔基-5-(1h-1,2,3-三唑-4-基)-1h-吲唑类化合物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CN102595899A (zh) * 2009-08-10 2012-07-18 埃皮瑟瑞克斯有限公司 作为wnt/b-联蛋白信号传导途径抑制剂的吲唑及其治疗用途
CA2819373A1 (en) * 2010-12-09 2012-06-14 Amgen Inc. Bicyclic compounds as pim inhibitors
PH12017500997A1 (en) * 2012-04-04 2018-02-19 Samumed Llc Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
WO2014137728A1 (en) * 2013-03-04 2014-09-12 Merck Sharp & Dohme Corp. Compounds inhibiting leucine-rich repeat kinase enzyme activity
WO2014134772A1 (en) * 2013-03-04 2014-09-12 Merck Sharp & Dohme Corp. Compounds inhibiting leucine-rich repeat kinase enzyme activity
CN106032359B (zh) * 2015-03-09 2018-07-20 复旦大学 吲唑类化合物及其制备方法和用途
MX380092B (es) * 2015-11-06 2025-03-11 Samumed Llc Tratamiento de la osteoartritis.
CN105958990B (zh) * 2016-05-24 2019-03-29 内蒙古包钢钢联股份有限公司 光电接近开关保护装置
WO2019241540A1 (en) * 2018-06-15 2019-12-19 Samumed, Llc Indazole containing macrocycles and therapeutic uses thereof
CA3118093A1 (en) * 2018-09-28 2020-04-02 Arizona Board Of Regents On Behalf Of The University Of Arizona Small molecule inhibitors of dyrk1/clk and uses thereof
US20230000842A1 (en) * 2019-01-17 2023-01-05 Samumed, Llc Methods of treating cartilage disorders through inhibition of clk and dyrk
WO2022012058A1 (zh) * 2020-07-16 2022-01-20 江苏凯迪恩医药科技有限公司 稠环化合物及其中间体、制备方法和应用
CN115353508B (zh) * 2022-08-24 2023-07-21 中国药科大学 5-吡啶-1h-吲唑类化合物、药物组合物和应用

Similar Documents

Publication Publication Date Title
JP2025515926A5 (https=)
JP2025037925A5 (https=)
JP2007523139A5 (https=)
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
EA201101089A1 (ru) Производные оксадиазола в качестве агонистов рецептора s1p1
CN113906013A (zh) 吡啶氮氧化合物及其制备方法和用途
NO20054523D0 (no) Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika
CY1114875T1 (el) Μεθοδος για παραγωγη παραγωγου αμινοθειαζολιου και παραγωγη ενδιαμεσου
RU2009138136A (ru) Новый способ получения соединения 2-гидрокси-3-[5-(морфолин-4-илметил)пиридин-2-ил]1н-индол-5-карбонитрила 701
JP2004527457A5 (https=)
DK1404317T3 (da) 5-Halogentryptaminderivater til anvendelse som ligander af 5-HT6- og/eller 5-HT7-serotoninreceptorer
AR088921A2 (es) PROCESO PARA LA PREPARACION DE DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTA mGluR5, COMPOSICIONES Y USO DE LOS COMPUESTOS
TR199701218T2 (xx) Benzimidazol bile�ikleri ve bunlar� i�eren farmakolojik bile�imler.
CY1110025T1 (el) Παραγωγα ισοξαζολινης και η χρηση αυτων ως ζιζανιοκτονα
CY1114932T1 (el) Αντιπαρασιτικοι παραγοντες
JP2023520330A5 (https=)
JP2006508979A5 (https=)
RU2010115337A (ru) Трициклические гетероциклические производные
JP2008537547A5 (https=)
JOP20240169A1 (ar) عمليات تحضير عوامل انحلال مستقبلات الإستروجين الانتقائية
CL2024003171A1 (es) Gamma-hidroxibutirato que administra compuestos y procesos para su fabricación y uso
ATE494292T1 (de) Eine pentakis(dimethylamino)disilanvorstufe enthaltende verbindung, und verfahren zu deren herstellung
CN116096713A (zh) 化合物的固体形式
JP2020510059A5 (https=)
DK1763534T3 (da) Nye 2-substituerede D-homo-estra-1,3,5(10)-triener som inhibitorer af 17beta-hydroxysteroiddehydrogenasen type 1